About us

 

Laxxon Medical Ltd owns the exclusive worldwide licensing rights for the commercial use of a patented 3D screen-printing process, developing and manufacturing an innovative Drug Delivery System for the controlled systemic release of pharmaceutical actives. Our goal is to grant selected companies in the pharmaceutical industry the appropriate licenses in their market segment for the manufacturing of their products using the 3D screen-printing process.